Mark R. Hazebroek

Macrophage MicroRNA-155 Promotes Cardiac Hypertrophy and Failure

Stéphane Heymans, Maarten F. Corsten, Wouter Verhesen et al. · Circulation · 2013 · 237 citations · Full text

Life Sciences, Cardiology, Physiology +16

MicroRNA Profiling Identifies MicroRNA-155 as an Adverse Mediator of Cardiac Injury and Dysfunction During Acute Viral Myocarditis

Maarten F. Corsten, Anna Papageorgiou, Wouter Verhesen et al. · Circulation Research · 2012 · 221 citations · Full text

Life Sciences, Cardiology, Pathobiology +17

Genetic Architecture of Acute Myocarditis and the Overlap With Inherited Cardiomyopathy

Amrit Lota, Mark R. Hazebroek, Pantazis Theotokis et al. · Circulation · 2022 · 163 citations · Full text

Life Sciences, Cardiology, Genetics +13

The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart ‘OMics’ in AGEing (HOMAGE) randomized clinical trial

John G.F. Cleland, João Pedro Ferreira, Beatrice Mariottoni et al. · European Heart Journal · 2020 · 143 citations · Full text

Medicine, Cardiology, Pharmacology +16

Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: Eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis

Mark R. Hazebroek, Michael J. Kemna, Simon Schalla et al. · International Journal of Cardiology · 2015 · 142 citations

Medicine, Cardiology, Internal Medicine +17